SU1688679A1 - Method of measurement of clozapin level in serum blood - Google Patents

Method of measurement of clozapin level in serum blood

Info

Publication number
SU1688679A1
SU1688679A1 SU4754216/14A SU4754216A SU1688679A1 SU 1688679 A1 SU1688679 A1 SU 1688679A1 SU 4754216/14 A SU4754216/14 A SU 4754216/14A SU 4754216 A SU4754216 A SU 4754216A SU 1688679 A1 SU1688679 A1 SU 1688679A1
Authority
SU
USSR - Soviet Union
Prior art keywords
clozapin
measurement
level
serum blood
serum
Prior art date
Application number
SU4754216/14A
Other languages
Russian (ru)
Inventor
Н.Д. Чекалина
М.Л. Беляева
Original Assignee
Всесоюзный научный центр психического здоровья АМН СССР
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Всесоюзный научный центр психического здоровья АМН СССР filed Critical Всесоюзный научный центр психического здоровья АМН СССР
Priority to SU4754216/14A priority Critical patent/SU1688679A1/en
Application granted granted Critical
Publication of SU1688679A1 publication Critical patent/SU1688679A1/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

FIELD: medicine, clinical pharmacology. SUBSTANCE: method involves the use of receptor material isolated from nucleus caudatus of bovine brain at concentration 21-25 micro g/ml. Receptor material is incubated with serum and radioactive ligand simultaneously. The sensitivity of clozapin determination by proposed method is increased by 4 times as compared with prototype. EFFECT: enhanced sensitivity of method.
SU4754216/14A 1989-07-20 1989-07-20 Method of measurement of clozapin level in serum blood SU1688679A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU4754216/14A SU1688679A1 (en) 1989-07-20 1989-07-20 Method of measurement of clozapin level in serum blood

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU4754216/14A SU1688679A1 (en) 1989-07-20 1989-07-20 Method of measurement of clozapin level in serum blood

Publications (1)

Publication Number Publication Date
SU1688679A1 true SU1688679A1 (en) 1994-07-15

Family

ID=60530684

Family Applications (1)

Application Number Title Priority Date Filing Date
SU4754216/14A SU1688679A1 (en) 1989-07-20 1989-07-20 Method of measurement of clozapin level in serum blood

Country Status (1)

Country Link
SU (1) SU1688679A1 (en)

Similar Documents

Publication Publication Date Title
IL97411A (en) Pharmaceutical formulations comprising hapten-modified diagnostic or therapeutic agents
GB2205643B (en) Type iii collagen degradation assay
EP0182634A3 (en) Antibodies and their production, diagnostic methods employing antibodies, and glycoproteins
AU7165987A (en) In vitro assay for detecting cell-mediated immune responses
IL96158A0 (en) Chemiluminescence assay of inflammation
SU1688679A1 (en) Method of measurement of clozapin level in serum blood
Dugas et al. Early events in human B cell activation: metabolic pathways vary according to the first signal used
DE3585049D1 (en) MONOCLONAL ANTIBODIES.
IE792390L (en) Hepatitis be antigen.
ZA872145B (en) Method for the detection of pregnancy disorders
Gilhus The in vitro effect of phenytoin and carbamazepine on subpopulations of human blood mononuclear cells
Asaka et al. Biochemical and clinical studies of aldolase isozymes in human cancer
Cohen et al. Agglutination of sensitized alligator erythrocytes by rheumatoid factor (s)
Murat et al. Questions about the use of [3H] thymidine incorporation as a reliable method to estimate cell proliferation rate.
ES8704268A1 (en) Method for determining the activity of the complement-system of blood.
FR2606151B1 (en) DETECTOR AND ITS APPLICATION TO THE ASSAY OF AN ANALYTE
ES2002578A6 (en) A process for the preparation of diagnostic reagents.
Turner et al. Neutrophil migration in response to chemotactic factors: effects of generation conditions and chemotherapeutic agents
GB2199326B (en) Polypeptidic composition useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of antimerozoite antibodies
Cox 8-methoxypsoralen-mediated impairment of human lymphocyte proliferation in vitro in the absence of ultraviolet irradiation: immunological and biochemical mechanisms
ES8500457A1 (en) A Method of Determining the Oxidizing Activity of a Biological Liquid, and a Mammalian Lens- derived Reagent for use in the Method
张世民 et al. The Receptor Role of Glycophorin A during the Invasion of Erythrocytes by Plasmodium Falciparum
JPS6421367A (en) Solid phase antibody for immunoassay
Kolomiĭtseva et al. Measurement of the 125I and 14C radioactivity in double-labeled blood samples
SU1475333A1 (en) Method of blood plasma toxicity assay